Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review.

ABSTRACT:

Introduction

Cognitive impairment is prevalent and debilitating among persons with multiple sclerosis (MS). While many pharmacologic treatments have shown good efficacy in reducing clinical relapses, brain lesions, and improving certain physical symptoms, their efficacy for improving cognitive function is not well understood.

Objectives

The current systematic review aimed to evaluate the efficacy of pharmacologic treatments for improving cognitive function among persons with MS.

Methods

A literature search was conducted through the PubMed and PsycINFO databases. Two independent reviewers assessed each paper, and a third reviewer weighed in if the two reviewers could not reach a consensus. Classification of evidence was determined using the 2017 American Academy of Neu

SUBMITTER: Chen MH 

PROVIDER: S-EPMC7275014 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature